Miguel Vazquez

Prof. Dr. Miguel Vazquez

Universidad de Guanajuato, División de Ciencias Naturales y Exactas, Departamento de Química
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2020 in ChemCatChem
Verified
Journal Article
Closed access
PDF file
JCJavier Cervantes‐González
Javier Cervantes‐González
DVDavid A. Vosburg
David A. Vosburg
SMSalma E. Mora‐Rodriguez
Salma E. Mora‐Rodriguez
MVMiguel Vazquez
Miguel Vazquez
GZGerardo Zepeda
Gerardo Zepeda
SLSELENE LAGUNAS-RIVERA
SELENE LAGUNAS-RIVERA

22 February 2012 in Chemical Science
Verified
Journal Article
Closed access
PDF file
ECEgoitz Conde
Egoitz Conde
DBDavide Bello
Davide Bello
ACAbel De Cózar
Abel De Cózar
MFMirian Sanchez Fernandez
Mirian Sanchez Fernandez
MVMiguel Vazquez
Miguel Vazquez
Fernando P. CossíoFernando P. Cossío
Fernando P. Cossío
(3 + 2) Cycloaddition reaction between azomethine ylides and π-deficient alkenes leads to densely substituted L- and D-unnatural prolines. These (3 + 2) cycloadducts in turn catalyse the preparation of an offspring of unnatural endo- and exo-L-proline derivatives. These latter compounds are also efficient catalysts of aldol reactions and yield aldol adducts with the opposite stereochemistry obtained under natural L-Pro organocatalysis.

19 April 2021 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
AFAlberto Feliciano
Alberto Feliciano
JVJuan L. Vázquez
Juan L. Vázquez
LBLuis J. Benítez‐Puebla
Luis J. Benítez‐Puebla
IVIván Velazco‐Cabral
Iván Velazco‐Cabral
DCDavid Cruz Cruz
David Cruz Cruz
MVMiguel Vazquez
Miguel Vazquez

1 September 2022 in Chemistry – An Asian Journal
Verified
Journal Article
Closed access
SMSalvador Mastachi‐Loza
Salvador Mastachi‐Loza
TRTania I. Ramírez‐Candelero
Tania I. Ramírez‐Candelero
LBLuis J. Benítez‐Puebla
Luis J. Benítez‐Puebla
AFAydeé Fuentes‐Benítes
Aydeé Fuentes‐Benítes
CGCarlos González‐Romero
Carlos González‐Romero
MVMiguel Vazquez
Miguel Vazquez

19 July 2015 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
JLJulio López
Julio López
FCFabiola N. De La Cruz
Fabiola N. De La Cruz
YAYolanda Alcaraz
Yolanda Alcaraz
FDFrancisco Delgado
Francisco Delgado
MVMiguel Vazquez
Miguel Vazquez
MAMiguel A.
Miguel A.

4 November 2020 in Molecules
Verified
Journal Article
Open access
PDF file
SGSantiago García
Santiago García
IMItzel Mercado-Sánchez
Itzel Mercado-Sánchez
Luis Cordova-BahenaLuis Cordova-Bahena
Luis Cordova-Bahena
YAYolanda Alcaraz-Contreras
Yolanda Alcaraz-Contreras
MGMarco Antonio García-Revilla
Marco Antonio García-Revilla
MVMiguel Vazquez
Miguel Vazquez
Coumarin-hydroxamic acid derivatives 7a–k were herein designed with a dual purpose: as antiproliferative agents and fluorescent probes. The compounds were synthesized in moderate yields (30–87%) through a simple methodology, biological evaluation was carried out on prostate (PC3) and breast cancer (BT-474 and MDA-MB-231) cell lines to determine the effects on cell proliferation and gene expression. For compounds 7c, 7e, 7f, 7i and 7j the inhibition of cancer cell proliferation was similar to that found with the reference compound at a comparable concentration (10 μM), in addition, their molecular docking studies performed on histone deacetylases 1, 6 and 8 showed strong binding to the respective active sites. In most cases, antiproliferative activity was accompanied by greater levels of cyclin-dependent kinase inhibitor p21, downregulation of the p53 tumor suppressor gene, and regulation of cyclin D1 gene expression. We conclude that compounds 7c, 7e, 7f, 7i and 7j may be considered as potential anticancer agents, considering their antiproliferative properties, their effect on the regulation of the genes, as well as their capacity to dock to the active sites. The fluorescent properties of compound 7j and 7k suggest that they can provide further insight into the mechanism of action.